Add like
Add dislike
Add to saved papers

Bi-exponential versus mono-exponential diffusion-weighted imaging for evaluating prostate cancer aggressiveness after radical prostatectomy: a whole-tumor histogram analysis.

Acta Radiologica 2019 March 22
BACKGROUND: The diagnostic efficacy of mono- and bi-exponential diffusion models are controversial in prostate cancer (PCa) aggressiveness evaluation. Whole-tumor histogram analysis may have the potential to improve their efficacy.

PURPOSE: To compare the efficacy of mono- and bi-exponential diffusion models for evaluating PCa aggressiveness using whole-tumor histogram analysis.

MATERIAL AND METHODS: In this retrospective study, 72 patients with PCa confirmed by radical prostatectomy were included. All patients underwent multi-b-value diffusion-weighted imaging (DWI). The mono-exponential model parameter (apparent diffusion coefficient [ADC]) and bi-exponential model parameters ( D, D*, and f ) were calculated and whole-tumor histogram analysis was performed. Tumor lesions were classified into low-grade (LG) and high-grade (HG) Gleason grade groups. Spearman analysis was used to evaluate the correlations between the histogram metrics and Gleason score (GS). The area under the receiver operating characteristic curve (AUC) was used to assess the discriminatory capacity of each parameter in distinguishing LG from HG PCa.

RESULTS: Most histogram metrics of ADC and D showed significant correlations with the GS. None of the histogram metrics of D* and only the maximum value and skewness of f showed significant correlations with GS. The 90th percentile ADC and 90th and 75th percentile D showed relatively higher efficacies than other histogram metrics. However, their AUCs were not significantly higher than that of mean ADC.

CONCLUSION: The bi-exponential model was not superior to the mono-exponential diffusion model for evaluating PCa aggressiveness. The histogram metrics did not outperform the conventional mean value.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app